Detalhe da pesquisa
1.
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.
Lancet Infect Dis
; 20(6): 719-730, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32199492
2.
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.
Lancet Infect Dis
; 20(6): 707-718, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32199491